Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-06

Clinical Trial Update: Native Kidney Denervation in Patients With End Stage Renal Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating native kidney denervation for end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Native kidney denervation device

Snippet

Sponsor: Medtronic Vascular | Conditions: End Stage Renal Disease | Phase 1 | Status: COMPLETED